Steven John Kemp

Dr

    • AB24 3UE

    • 131 Citations
    20002015
    If you made any changes in Pure these will be visible here soon.

    Fingerprint Dive into the research topics where Steven John Kemp is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 21 Similar Profiles
    tau Proteins Chemical Compounds
    Proteolysis Chemical Compounds
    Amination Chemical Compounds
    Diamines Chemical Compounds
    Agglomeration Chemical Compounds
    Patents and inventions Chemical Compounds
    Salts Chemical Compounds
    Hydrates Chemical Compounds

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 2000 2015

    • 131 Citations
    • 4 Article
    • 2 Patent
    39 Citations (Scopus)
    5 Downloads (Pure)
    Open Access
    File
    Proteolysis
    Alzheimer Disease
    Agglomeration
    Brain
    Salts

    Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants

    Larch, C. P., Storey, J. M. D., Williamson, C., Marshall, C. & Kemp, S. J., 8 Mar 2012, IPC No. AA61K315415FI , Patent No. 20120058995

    Research output: Patent

    File
    tau Proteins
    Hydrates
    Labels
    Salts
    Ligands
    12 Citations (Scopus)

    A stable oxoverdazyl free radical: Structural and magnetic characterization

    Plater, M. J., Kemp, S., Coronado, E., Gomez-Garcia, C. J., Harrington, R. W. & Clegg, W., Aug 2006, In : Polyhedron. 25, 12, p. 2433-2438 6 p.

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    New tetrahydro-1,2,4,5-tetrazinan-3-ones and oxoverdazyl free radicals

    Plater, M. J., Sinclair, J. P., Kemp, S., Gelbrich, T., Hursthouse, M. B. & Gómez-García, C. J., 1 Aug 2006, In : Journal of Chemical Research. 8, 8, p. 515-520 6 p.

    Research output: Contribution to journalArticle

    Impacts

    Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease

    Claude Michel Wischik (Participant), Charles Robert Harrington (Participant), John Mervyn David Storey (Participant), Janet Elizabeth Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven John Kemp (Participant), James Peter Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant), C Marshall (Participant)

    Impact: Quality of life Impacts, Economic Impacts